Cathy Barton16 hours ago
Has anyone heard anything else about the placebo story? A poster on here way back found an article saying it was 60/40 vaccine/ placebo as they needed to keep adverse effects below a certain threshold. I can’t find the post on here and google turn up nothing although with everything else that is happening it seems likely.
Also, any updates on “shedding”? A guy I work pretty close to in the lab got a booster. I would have said I was 95% better but all original symptoms suddenly came back 100% including bladder infection type symptoms that I only had with the first jab and excessive urination. I was unaware he got the booster until he took a sick day and I found out. There are only 3 of us in this particular area. I now also have new symptoms such as dizzy ,floaty/ boaty feeling and my muscles feel like I ran a marathon. Thoughts?
I started noticeable symptoms 4 days after his booster.
Dr. satyam archana16 hours ago
Have urinary symptoms amongst many others in my patients
Ellie S15 hours ago
Home - ClinicalTrials.gov is a good source to find out more about placebos, dosing, and changing formulations of the vax. These are all variables that are in flux so a ratio would be difficult to establish.
Since this is an experiment you do have the right to complete informed consent including all possible negative outcomes and to refuse it completely under law.
As Wayne Sims already stated, a mandate requires your voluntary consent.
To understand the system fully please read Murder by Injection by Eustace Mullins.
Wayne Sims14 hours ago
Hello @Cathy Barton,
I believe I located what you were looking for and it's located in Phizer's own documentation PF-07302048 (BNT162 RNA-Based COVID-19 Vaccines) Protocol C4591001 titled, "A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals". (
https://tinyurl.com/36cpa685) The PDF link was posted June 16th and reposted on Aug 15th which addresses both.
The ratio of active vaccine to placebo -
It describes the [ratio of active vaccine to placebo] as 100 × (1 – IRR)
Under "Number pf Participents"
- Each group in Phase 1 will comprise 15 participants (12 receiving the active vaccine and 3 receiving placebo)
- The vaccine candidate selected for Phase 2/3, BNT162b2 at a dose of 30 µg, will comprise 21,999 vaccine recipients. The 12- to 15-year stratum will comprise up to approximately 2000 participants (1000 vaccine recipients) enrolled at selected investigational sites. It is intended that a minimum of 40% of participants will be in the >55-year stratum. An equal number of participants will receive placebo, ie, randomized in a 1:1 ratio.
Shedding/transmission of infectious particles -
The evidence of the Pfizer injection transmitting to others ("exposure to the study intervention") can be found on pages 67, 68, 69 of the clinical trial documentation.
You may also find it worth the read and very more interesting data in the PDF, I certainly did, especially under the heading of "Overall Design".
WE are the experiment!
Wayne Sims10 hours ago
@Cathy Barton I was doing a little further reading in the same document which can also be found here (
https://cdn.pfizer.com/pfizercom/2020-11/C4591001_Clinical_Protocol_Nov2020.pdf) in reference to specifics around each of the 3 phases and can conclude by their own statements, (if I am reading it correctly) the phases are as follows: (at least they were when the PDF was published).
A. 1st phase 75% Active/25% Placebo
B. 2nd phase 50% Active/50% Placebo
C. 3rd Phase 50% Active/50% Placebo
They go on to break things down even further by age group/outcome, dose 1 followed by subsequent doses, etc but I'll let others read into that if they wish.
Cathy Barton8 hours ago
Thank you!
Ron Reynolds Anesthesia L2 Technologist7 hours ago
Very welcome Cathy. Hopefully that is what you were looking for.
Ellie S3 hours ago
Would this apply to the general population as well?